Articles tagged with Hormone Therapy
Researchers have identified UCHL1, a protein found in highly aggressive neuroendocrine carcinomas and neuroblastoma, as a potential molecular biomarker for diagnosing these cancers and predicting responses to therapy. Targeting UCHL1 with inhibitors has been shown to delay the growth and spread of these tumors in pre-clinical models.
A Phase 3 clinical trial found that combining testosterone-blocking drugs prevents cancer spread and extends treatment time in patients with relapsed prostate cancer. The approach is more effective than single-drug treatment in delaying cancer progression.
Researchers identified genetic variants that predict response to treatment for preterm birth, a condition affecting one in 10 infants. High levels of mutations in certain genes are associated with lower response rates, suggesting a precision framework for future drug development.
Researchers found a significant connection between anxiety disorders and the brain receptor TACR3, as well as low testosterone levels. Testing showed that inhibiting TACR3 resulted in increased receptors on the cell surface, blocking long-term synaptic strengthening.
A pioneering study published in The American Journal of Pathology reveals the cytoprotective and proregenerative effects of neuropeptide α-MSH in promoting corneal healing after eye injury. The treatment has shown impressive therapeutic potential in reducing the need for corneal transplants.
Researchers found that kisspeptin neurons with dynorphin receptors are crucial for hormone secretion and ovulation. The study provides new insights into the central mechanism underlying reproduction and may lead to treatment of ovarian disorders.
Scientists at the University of Washington School of Medicine developed a novel protein design approach using AI, creating proteins that bind to challenging biomarkers with exceptionally high affinity and specificity. The breakthrough has implications for drug development, disease diagnosis, and environmental monitoring.
Suicide rates in the US increased across all racial groups between 1999 and 2020, with highest rates among White people and American Indian/Alaska Native persons. Firearms and hanging were the top methods used, with a sharp increase in hangings among women.
A new study finds that a hormone produced by the fetus and a mother's sensitivity to it are the causes behind nausea and vomiting during pregnancy. Lowering GDF15 levels or pre-exposing women to the hormone may mitigate symptoms, providing potential ways to prevent extreme forms of pregnancy sickness.
Scientists in Brazil have developed a method to obtain a substance similar to estrogen from soy isoflavones, which may help alleviate menopause symptoms. The researchers extracted equol from soybean oil production residue and found it to be more bioavailable than glycosylated forms.
A phase 3 trial found that tirzepatide promotes additional weight loss and preserves metabolic health when continued, but discontinuation leads to significant weight regain. Researchers suggest chronic treatment may be necessary for sustained weight loss and improved cardiometabolic risk factors.
Researchers at Weill Cornell Medicine discovered a genetic variant in the GIP receptor that may help individuals resist obesity. The variant enhances insulin release and glucose metabolism, allowing mice with the variant to process sugar more efficiently and stay leaner.
Researchers developed a predictive model using baseline sociodemographic and financial measures to identify patients at high risk of stopping treatment with aromatase inhibitors. The model found four demographic and financial factors associated with increased non-adherence, including younger age and lower out-of-pocket costs.
Two studies led by UCLA researchers reveal how cancer cells use energy to survive and grow, shedding light on why some prostate cancers become resistant to hormone therapy. The findings highlight the importance of considering cell metabolism in developing new cancer treatments, particularly those targeting the androgen receptor.
A new study found Black men diagnosed with advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy compared to white or Latino men. The disparity persisted at five years and beyond, with Black patients receiving this crucial treatment at a lower rate.
A clinical trial by researchers at Washington University School of Medicine found routine thyroid hormone intervention to be ineffective in preserving heart function and increasing organ availability for transplantation. The practice may even cause harm, prompting the authors to recommend halting its use.
A new study from Johns Hopkins Medicine finds that excess thyroid hormone levels are associated with a higher risk of cognitive disorders in older adults. The research suggests that clinicians should avoid overtreatment when prescribing thyroid hormone therapy to prevent potential negative consequences.
Mount Sinai researchers have found that testosterone treatment is safer than previously reported, with a smaller degree of change in hematocrit levels. The study, involving over 6,670 transmasculine patients, suggests that providers can feel more comfortable prescribing testosterone as part of gender-affirming hormone therapy.
Researchers found that immunomodulatory drugs used to treat rheumatoid arthritis can reduce the risk of autoimmune thyroid diseases. Patients treated with these drugs had a 46% lower risk of developing an autoimmune thyroid disease compared to those without rheumatoid arthritis.
Researchers identified a correlation between the HSD3B1 biomarker and resistance to combined hormone therapy and radiotherapy in men with prostate cancer. The study found that high levels of the enzyme led to increased testosterone production, promoting resistance to treatment.
Jenny Wilkerson receives $1.94 million grant to develop novel models and investigate antinociceptive profiles of basal sex hormone alterations in patients with chronic post-op pain. The study aims to answer questions about the impact of altered sex hormone levels on recovery times, drug effectiveness, and long-term health.
A single dose of zilebesiran safely and effectively lowered systolic blood pressure in people with mild-to-moderate high blood pressure for up to six months. The study found significant reductions in daytime and nighttime systolic blood pressure, as well as low rates of adverse events.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
Experts call for urgent measures to address discrimination against patients fleeing war or conflict zones, those with serious mental illnesses, and frail elderly patients. Guidelines for treating advanced breast cancer should prioritize patient preferences and involve multidisciplinary care teams.
A mouse model study found that testosterone treatment decreased egg yield without affecting quality, but outcomes improved with a washout period. This research provides evidence to inform fertility care for transgender and gender diverse people who wish to become parents.
Researchers at MUSC Hollings Cancer Center have identified new targets for treating breast cancer that has become resistant to hormone therapy and CDK4/6 inhibitors. By understanding the molecular mechanisms of resistance, the team has found potential solutions using epidermal growth factor receptors and PARP inhibitors.
Researchers found that FAAH inhibition reduced breast cancer growth in immunodeficient mice and induced apoptosis of breast cancer cells. The combination of FAAH inhibitors and endocannabinoids was the most effective treatment approach.
A new study finds that systemic therapies for advanced prostate cancer are equally effective for Black men as they are for white men, regardless of socioeconomic status. The research suggests that disparities in healthcare can be eliminated with equal access to treatment.
A new versatile platform controls peptide hormones in fish, revealing surprising findings about conserved genetic networks and adaptable hormone regulation. This innovative method holds promise for transforming fish farming practices and exploring ways to prolong vertebrate lifespan.
A new hormone replacement therapy, Pulsatility, has shown promising results in improving symptoms and quality of life for patients with adrenal insufficiency conditions. The treatment, which delivers hydrocortisone in a pulsatile pattern, decreased fatigue by 10% and improved mood and energy levels by 30%.
A new study reveals female sex hormones play a crucial role in how Alzheimer's manifests in the brain, with estradiol contributing to variation in beta-amyloid protein regulation. This understanding is necessary for developing targeted therapies.
Researchers classify UGDH as a molecular indicator of tumor progression in multiple cancer types, describing its involvement in key canonical cancer signaling pathways. Methods to inhibit UGDH and its downstream products are also identified.
A worldwide audit of testosterone deficiency in men with type 2 diabetes found that testosterone replacement therapy improves glycaemic control for up to 2 years. The study suggests that the ongoing effect of testosterone on insulin resistance and fat reduction contributes to the improvement in blood sugar levels.
Men with metastatic prostate cancer in Sweden experienced an average survival rate increase of six months after dual treatment was introduced from 2016 onwards. This improvement coincides with the gradual rollout of 'dual treatment', combining standard hormone therapy and chemotherapy or androgen receptor blockers.
A new study published in Exp. Mol. Med. has identified Thrap3 as a key player in exacerbating non-alcoholic fatty liver disease (NAFLD) by inhibiting AMPK, a crucial regulator of fat metabolism. Inhibiting Thrap3 expression presents a promising avenue for treating NAFLD.
A new study links menopause to cognitive deficits, revealing estrogen receptor beta's crucial role in astrocytes. Midlife female mice showed cognitive impairment after losing ovarian hormones, and brain atrophy was observed in the dorsal hippocampus.
Researchers at Caltech developed a wearable sensor that detects estradiol levels in sweat, allowing for real-time monitoring of female hormones. The sensor can track changing estradiol levels throughout the reproductive cycle, providing valuable insights for fertility and hormone replacement therapy.
Researchers analyze neuroendocrine tumors at single cell resolution, unlocking key insights into tumor biology and potential evolution of tumor characteristics. The study reveals heterogeneity within tumor subtypes and identifies potential targets for immunotherapy treatment.
A multidisciplinary team investigates hospital wastewater samples and demonstrates the effectiveness of photocatalytic treatment in reducing pharmaceutically active compounds and bacteria. The study highlights the challenges posed by antibiotic-resistant bacteria and suggests a promising step towards sustainable wastewater treatment.
A study published in The Journal of Physiology found that exercise suppresses hunger by acting on hormones and metabolites. Researchers suggest that understanding these mechanisms could lead to new treatments for obesity.
A study found that severe erythrocytosis, where hematocrit is over 54%, is a rare outcome of testosterone therapy in adults. Researchers recommend reevaluating the need for frequent lab screenings to minimize unnecessary draws among patients who prefer not to undergo regular checks.
Researchers found that beta-blockers can revive exhausted killer T cells, making them better cancer fighters. The study discovered a link between the sympathetic stress response and immune system response to cancer.
A new study found pediatric endocrinologists are concerned about threats to their personal safety and the impact of transgender health bans on medical practice. The researchers surveyed 223 pediatric endocrinologists, with 56% providing gender-affirming care, and identified safety concerns, pressures on hospitals, and threats against p...
Researchers developed a personalized combination treatment that turned on an immunometabolic switch to effectively control aggressive prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.
Researchers identified distinct genomic characteristics that impact prognosis for patients with triple negative apocrine carcinoma. The study confirmed a five-year disease-free survival rate of 92.2% for these patients, significantly higher than those diagnosed with other types of TNBC.
Researchers discovered NSMF protein's role in alleviating DNA replication stress by displacing weakly bound RPA proteins and promoting phosphorylation. This mechanism accelerates relief of replication stress, offering a new direction for treating various diseases, including cancer and age-related conditions.
A randomized clinical trial found immediate testosterone therapy significantly reduced gender dysphoria, depression, and suicidality in transgender and gender-diverse individuals. The study included 64 participants and compared immediate testosterone therapy to no treatment.
A comprehensive review of over 70 years of menopause science emphasizes the need for more research into symptom timeline and treatment effectiveness. The authors advocate for holistic, individualized approaches addressing physical and mental health impacts of menopause.
Residency programs lack standardized menopause curriculum, with only 31% reporting any training. A national curriculum is proposed to improve patient care and address the growing need for menopause education.
A recent study published in The Lancet found that home-monitoring during IVF is just as effective as hospital checks, with similar pregnancy rates and fewer complications. This approach also reduces costs by up to 80% and has numerous environmental benefits.
Scientists at UCSF have developed an artificial kidney that can mimic key functions of a real kidney. The bioreactor keeps kidney cells alive for up to seven days and has shown promising results in animal trials. If successful, the device could improve treatment for kidney disease, making it more effective, tolerable, and comfortable.
A new study from the University of Copenhagen reveals that GDF15 improves insulin sensitivity in rodents, particularly in their liver and fatty tissue. This finding raises interesting perspectives for treating type 2 diabetes and high blood pressure, as increased insulin sensitivity is a critical indicator of health.
A study published in JAMA Network Open found that many websites selling fertility tests make misleading claims about their effectiveness and limitations. The researchers called for increased regulation and oversight on the marketing of home fertility tests, which can lead to false reassurance or worry among women.
A recent study by Pennington Biomedical Research Center identifies GDF15 as a protein that acts as a cellular signal to enhance insulin secretion. High-intensity exercise training in patients with type 2 diabetes was found to have elevated levels of GDF15, associated with improved glycemic control.
Researchers have identified a neoplastic fusion transcript RAD51AP1-DYRK4 in luminal B breast cancer, associated with higher ki67 expression and aggressive clinical characteristics. MEK inhibitor trametinib may be effective in blocking the MEK-ERK signaling driven by this fusion.
LSU Health researchers found combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases effectiveness in experimental models of ER+ and TNBC. The study's findings suggest a new approach for treating treatment-resistant breast cancers.
A new study reveals that rapid state law changes mean many families will need to drive longer distances to access gender-affirming care for their transgender children. The restrictions have led to 25% of Americans aged 10-17 living more than a day's drive away from a clinic offering such care.
Brigham researchers use induced pluripotent stem cells to restore hormone production and fertility in mice with premature ovarian failure. The study shows promise for treating incurable conditions and may lead to new therapies for patients with ovarian failure.
Researchers have discovered a mechanism leading to resistance in luminal breast cancer and propose using the approved osteoporosis drug denosumab to block RANK protein, promoting effectiveness of CDK4/6 inhibitors. This could lead to new treatment options for patients with metastatic breast cancer.
A new study by researchers at Dartmouth Cancer Center shows that a combination of estrogen and PARP inhibitors can effectively treat advanced ER+ breast cancer by damaging cancer cells and preventing DNA repair. The treatment strategy has been shown to be effective regardless of BRCA1 or BRCA2 genetic mutations.